Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T1120 |
Dacarbazine
Imidazole Carboxamide,达卡巴嗪,DTIC-Dome |
Apoptosis; Nucleoside Antimetabolite/Analog; DNA/RNA Synthesis | Apoptosis; Cell Cycle/Checkpoint; DNA Damage/DNA Repair |
Dacarbazine (DTIC-Dome) 是一种抗肿瘤剂,对黑色素瘤具有显着的活性。 | |||
T1120L |
Dacarbazine hydrochloride
Dacarbazine HCl |
||
Dacarbazine ( imidazole carboxamide) is a chemotherapy drug used to treat melanoma and Hodgkin's lymphoma. | |||
T1120L2 |
Dacarbazine citrate
DTIC citrate |
||
Dacarbazine citrate is an alkylating agent used to treat cancers of the lymphatic system and malignant melanoma (a type of skin cancer) in patients with certain conditions: islet cell carcinoma (part of the pancreas) Soft tissue sarcoma (cancer of muscles | |||
T16433 |
Pancopride
LAS 30451 |
5-HT Receptor | GPCR/G Protein; Neuroscience |
Pancopride(LAS 30451) 是一种可口服的新型有长效的选择性 5-HT3 受体拮抗剂,可阻断氮芥和达卡巴嗪诱导的呕吐。 | |||
T71768 | CB10-277 | ||
CB10-277 is a synthetic derivative of dimethylphenyl-triazene related to dacarbazine, with antineoplastic properties. Related to the agent dacarbazine, CB10-277 is converted in vivo to a monomethyl triazene form that alkylates DNA, resulting in inhibition of DNA replication and repair; in addition, this agent may act as a purine analogue, resulting in inhibition of DNA synthesis, and may interact with protein sulfhydryl groups. | |||
T60475 |
RRD-251
|
||
RRD-251 是一种(Rb)-Raf-1相互作用抑制剂,可诱导转移性黑色素瘤细胞凋亡并能与达卡巴嗪协同作用,具有抗增殖、抗血管生成和抗肿瘤活性。 |